Share This Author
Heart rate variability. Standards of measurement, physiological interpretation, and clinical use
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special…
An update of the 2010 ESC Guidelines for the management of atrial fibrillation with the special contribution of the European Heart Rhythm Association is developed.
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special…
A prospective, randomized, double blind, Active-controlled, superiority study of Vernakalant vs. amiodarone in Recent Onset atrial fibrillation for the prevention of cardiovascular Hospitalization or death from any cause.
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug…
Universal definition of myocardial infarction.
The document is based on the Fourth Universal Definition of Myocardial Infarction, developed jointly by experts from the European Society of Cardiology (ETC) / American College of Cardiology (ACC) /…
Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.
This survey provides a unique snapshot of current AF management in ESC member countries and found Discordance between guidelines and practice was found regarding several issues on stroke prevention and antiarrhythmic therapy.
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II